NPS Pharmaceuticals


Takeda China is a subsidiary of Takeda Pharmaceutical Company Limited, a global leader in the pharmaceutical industry dedicated to innovative research and development to improve human health. Established in 1994, Takeda China focuses on providing a wide range of products to meet the needs of Chinese patients, with operations including sales, research, manufacturing, and distribution across major cities. The company emphasizes corporate social responsibility, employee well-being, and sustainable development, actively engaging in community support and environmental initiatives. Takeda China aims to be a trusted partner in healthcare, delivering high-quality medicines and contributing to the health and well-being of society.

Industries

biotechnology
health-care

Nr. of Employees

Very Large (1000+)

NPS Pharmaceuticals

36-37F, No. 555 Haiyang West Road, Pudong New Area, Shanghai, China


Patents

Treatment of short bowel syndrome patients with colon-in-continuity

US-9999656-B2

View Details

Treatment of short bowel syndrome patients with colon-in-continuity

US-9993528-B2

View Details

Treatment of short bowel syndrome patients with colon-in-continuity

US-9987335-B2

View Details

Treatment of short bowel syndrome patients with colon-in-continuity

US-9987334-B2

View Details

Treatment of short bowel syndrome patients with colon-in-continuity

US-9981015-B2

View Details

Treatment of short bowel syndrome patients with colon-in-continuity

US-9981016-B2

View Details
View All Patents

Products

Oral small-molecule therapies for type 2 diabetes (DPP‑4 inhibitor class and fixed-dose combinations)

Oral antidiabetic small-molecule agents including DPP‑4 inhibitor-class monotherapy and fixed-dose combination oral formulations with other antihyperglycemic agents.


Services

Design and conduct of Phase I–III multicenter randomized clinical trials, including safety monitoring and data analysis.

Commercial drug manufacturing at GMP-compliant production facilities with associated sustainability initiatives.

Preparation and management of regulatory filings and established channels for adverse event and product quality reporting.

Management of trade, importation, national distribution centers and warehousing operations to support medicine supply.

Expertise Areas

  • Clinical trial management and execution
  • Regulatory affairs and compliance (global and regional filings)
  • GMP pharmaceutical manufacturing and site operations
  • Supply chain, importation and national distribution
  • Show More (4)

Key Technologies

  • GMP-compliant pharmaceutical production
  • Large-scale randomized multicenter clinical trials
  • Independent data monitoring and safety committees
  • Pharmacovigilance systems and adverse event reporting
  • Show More (4)

News & Updates

Takeda China Celebrates 30 Years of Innovation

Takeda China commemorates its 30th anniversary with a series of events highlighting its contributions to healthcare.

Environmental Sustainability Initiatives

Takeda China launches new green initiatives to reduce carbon footprint and promote environmental health.

Community Support and CSR Activities

Takeda China actively participates in community health programs and social responsibility projects.

Takeda's Commitment to Human Health in China

An overview of Takeda's mission and activities in China to improve patient lives.

Innovations in Pharmaceutical R&D at Takeda China

Insights into recent research breakthroughs and development efforts.

Takeda China Employee Stories

Profiles of employees contributing to Takeda's success and culture.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.